These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10447918)

  • 1. Costimulation of CD28- T cells through CD3 and beta1-integrins induces a limited Th1 cytokine response.
    Saukkonen JJ; Tantri A; Berman J
    Scand J Immunol; 1999 Aug; 50(2):145-9. PubMed ID: 10447918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte stimulation by CD3-CD28 enables detection of low T cell interferon-gamma and interleukin-4 production in rheumatoid arthritis.
    Verhoef CM; Van Roon JA; Vianen ME; Glaudemans CA; Lafeber FP; Bijlsma JW
    Scand J Immunol; 1999 Oct; 50(4):427-32. PubMed ID: 10520184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Costimulation of CD3/TcR complex with either integrin or nonintegrin ligands protects CD4+ allergen-specific T-cell clones from programmed cell death.
    Agea E; Bistoni O; Bini P; Migliorati G; Nicoletti I; Bassotti G; Riccardi C; Bertotto A; Spinozzi F
    Allergy; 1995 Aug; 50(8):677-82. PubMed ID: 7503404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergy between CD28 and CD9 costimulation for naive T-cell activation.
    Toyo-oka K; Tai XG; Yashiro Y; Ahn HJ; Abe R; Hamaoka T; Kobayashi M; Neben S; Fujiwara H
    Immunol Lett; 1997 Jun; 58(1):19-23. PubMed ID: 9436464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of cytokine polymorphic inheritance and in vitro cytokine production in anti-CD3/CD28-stimulated peripheral blood lymphocytes.
    Hoffmann SC; Stanley EM; Darrin Cox E; Craighead N; DiMercurio BS; Koziol DE; Harlan DM; Kirk AD; Blair PJ
    Transplantation; 2001 Oct; 72(8):1444-50. PubMed ID: 11685118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-2 receptor blockade inhibits late, but not early, IFN-gamma and CD40 ligand expression in human T cells: disruption of both IL-12-dependent and -independent pathways of IFN-gamma production.
    McDyer JF; Li Z; John S; Yu X; Wu CY; Ragheb JA
    J Immunol; 2002 Sep; 169(5):2736-46. PubMed ID: 12193748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of mRNA stability in the different patterns of cytokine production by CD4+ cells from young and old mice.
    Pioli C; Pucci S; Barile S; Frasca D; Doria G
    Immunology; 1998 Jul; 94(3):380-7. PubMed ID: 9767421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin 12 synergizes with B7/CD28 interaction in inducing efficient proliferation and cytokine production of human T cells.
    Kubin M; Kamoun M; Trinchieri G
    J Exp Med; 1994 Jul; 180(1):211-22. PubMed ID: 7516408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-10 directly acts on T cells by specifically altering the CD28 co-stimulation pathway.
    Joss A; Akdis M; Faith A; Blaser K; Akdis CA
    Eur J Immunol; 2000 Jun; 30(6):1683-90. PubMed ID: 10898505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligation of CD28 on resting T cells by its ligand B7 results in the induction of both Th1- and Th2-type cytokines.
    Walter H; Schepensn S; Van Wauwe J; de Boer M
    Eur Cytokine Netw; 1994; 5(1):13-21. PubMed ID: 7519453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T helper-independent activation of human CD8+ cells: the role of CD28 costimulation.
    Van Gool SW; Zhang Y; Kasran A; de Boer M; Ceuppens JL
    Scand J Immunol; 1996 Jul; 44(1):21-9. PubMed ID: 8693288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different cytokine and stimulation conditions influence the expansion and immune phenotype of third-generation chimeric antigen receptor T cells specific for tumor antigen GD2.
    Gargett T; Brown MP
    Cytotherapy; 2015 Apr; 17(4):487-95. PubMed ID: 25573334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD28 is not required for c-Jun N-terminal kinase activation in T cells.
    Rivas FV; O'Herrin S; Gajewski TF
    J Immunol; 2001 Sep; 167(6):3123-8. PubMed ID: 11544297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of experimental blood stage malaria through blockade of the B7/CD28 T-cell costimulatory pathway.
    Taylor-Robinson AW; Smith EC
    Immunology; 1999 Mar; 96(3):498-504. PubMed ID: 10233733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific activation of resting T cells against tumour cells by bispecific antibodies and CD28-mediated costimulation is accompanied by Th1 differentiation and recruitment of MHC-independent cytotoxicity.
    Hombach A; Tillmann T; Jensen M; Heuser C; Sircar R; Diehl V; Kruis W; Pohl C
    Clin Exp Immunol; 1997 May; 108(2):352-7. PubMed ID: 9158110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PI3-kinase and MAP-kinase signaling cascades in AILIM/ICOS- and CD28-costimulated T-cells have distinct functions between cell proliferation and IL-10 production.
    Okamoto N; Tezuka K; Kato M; Abe R; Tsuji T
    Biochem Biophys Res Commun; 2003 Oct; 310(3):691-702. PubMed ID: 14550257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ICOS cooperates with CD28, IL-2, and IFN-gamma and modulates activation of human naïve CD4+ T cells.
    Mesturini R; Nicola S; Chiocchetti A; Bernardone IS; Castelli L; Bensi T; Ferretti M; Comi C; Dong C; Rojo JM; Yagi J; Dianzani U
    Eur J Immunol; 2006 Oct; 36(10):2601-12. PubMed ID: 17013990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary defect in CD8+ lymphocytes in the antibody deficiency disease (common variable immunodeficiency): abnormalities in intracellular production of interferon-gamma (IFN-gamma) in CD28+ ('cytotoxic') and CD28- ('suppressor') CD8+ subsets.
    North ME; Webster AD; Farrant J
    Clin Exp Immunol; 1998 Jan; 111(1):70-5. PubMed ID: 9472663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD8+ cells and not CD4+ T cells are hyporesponsive to CD28- and CD40L-mediated activation in HIV-infected subjects.
    Vingerhoets J; Kestens L; Penne G; De Vuyst H; Vandenbruaene M; Pelgrom Y; Bosmans E; de Boer M; Kasran A; Azuma M; Colebunders R; Ceuppens JL; Vanham G
    Clin Exp Immunol; 1997 Mar; 107(3):440-7. PubMed ID: 9067514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
    Bian Y; Hiraoka S; Tomura M; Zhou XY; Yashiro-Ohtani Y; Mori Y; Shimizu J; Ono S; Dunussi-Joannopoulos K; Wolf S; Fujiwara H
    Int Immunol; 2005 Jan; 17(1):73-83. PubMed ID: 15569772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.